cbdMD (YCBD) EBT (2016 - 2025)

cbdMD has disclosed EBT across 10 years of filings, most recently posting -$283131.0 for Q4 2025.

• EBT for Q4 2025 came in at -$283131.0, down 1975.66% year-over-year; the trailing twelve-month figure through Dec 2025 was -$2.3 million (up 13.0% YoY), and the FY2025 annual result was -$2.0 million, up 44.84% from the prior year.
• EBT came in at -$283131.0 for Q4 2025 at cbdMD, up from -$679968.0 in the prior quarter.
• In the past five years, EBT ranged from a high of $1.6 million in Q2 2021 to a low of -$31.6 million in Q2 2022.
• The 5-year median for EBT is -$1.6 million (2023), against an average of -$5.7 million.
• Across the five-year window, EBT plunged 2028.57% in 2022 and soared 125.97% in 2024, its largest moves.
• cbdMD's EBT stood at -$19.2 million in 2021, then soared by 79.35% to -$4.0 million in 2022, then soared by 74.81% to -$996501.0 in 2023, then jumped by 101.51% to $15095.0 in 2024, then slumped by 1975.66% to -$283131.0 in 2025.
• The last three EBT figures came in at -$283131.0 (Q4 2025), -$679968.0 (Q3 2025), and -$895272.0 (Q2 2025), per Business Quant data.